Viking Global Investors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-7,793,397
Closed -$792M 65
2015
Q4
$792M Buy
7,793,397
+2,800,044
+56% +$315M 2.99% 13
2015
Q3
$891M Buy
4,993,353
+376,615
+8% +$87.8M 3.41% 7
2015
Q2
$1.03B Buy
4,616,738
+558,395
+14% +$124M 3.87% 6
2015
Q1
$806M Sell
4,058,343
-5,018,664
-55% -$890M 3.12% 12
2014
Q4
$1.3B Sell
9,077,007
-890,683
-9% -$120M 5.96% 3
2014
Q3
$1.31B Sell
9,967,690
-1,863,242
-16% -$222M 5.25% 3
2014
Q2
$1.49B Buy
11,830,932
+2,534,789
+27% +$323M 6.51% 2
2014
Q1
$1.23B Buy
9,296,143
+967,139
+12% +$132M 5.14% 4
2013
Q4
$978M Sell
8,329,004
-620,604
-7% -$68M 4.56% 4
2013
Q3
$934M Sell
8,949,608
-542,648
-6% -$52.9M 5.15% 4
2013
Q2
$817M Buy
+9,492,256
New +$748M 4.54% 7

Other funds holding BHC

Viking Global Investors's BHC Position: Q1 2016 in Review

Viking Global Investors sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 7,793,397 shares — an estimated $792M sold.

Viking Global Investors first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $1.49B in Q2 2014. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Viking Global Investors reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Viking Global Investors sold 7,793,397 Bausch Health shares in Q1 2016, an estimated $792M.
  • Viking Global Investors first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • Viking Global Investors's Bausch Health position peaked at $1.49B in Q2 2014.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Viking Global Investors's 13F filing for Q1 2016, filed 16 May 2016.